Intervene Immune Publishes Thymus Regrowth Trial Results

Intervene Immune is the company formed to commercialize the methology for regrowth of thymic tissue used in the small TRIIM (Thymus Regeneration, Immunorestoration, and Insulin Mitigation) trial, a combination of growth hormone, DHEA, and metformin. As I’ve noted in the past, that the approach involves the use of human growth hormone over an extended period of time makes it less desirable as an intervention, but if one can gain an expectation of some thymic regeneration, leading to an extended improvement in immune function that lasts for years beyond the treatment period, then it might be worth the trade-off. In general, higher growth hormone levels are associated with a worse outcome in the study of aging, while lower levels are associated with a slowing of aging. Using

from http://besthealthnews.com/2019/09/intervene-immune-publishes-thymus-regrowth-trial-results/?utm_source=rss&utm_medium=rss&utm_campaign=intervene-immune-publishes-thymus-regrowth-trial-results

from
https://healthnews010.tumblr.com/post/187615032198

from https://johnher1.blogspot.com/2019/09/intervene-immune-publishes-thymus.html

from
https://johnher10.tumblr.com/post/187615274532

From https://stevenbrown1.blogspot.com/2019/09/intervene-immune-publishes-thymus.html

from
https://stevenbrown11.wordpress.com/2019/09/10/intervene-immune-publishes-thymus-regrowth-trial-results/